Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

RIPK1 inhibitors might help prevent alopecia areata.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

IL-27 can prevent hair loss in alopecia areata.

taVNS reduces vitiligo symptoms in mice.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

ILC1-like cells may contribute to hair loss in alopecia areata.

Mitochondrial stress can lead to atopic dermatitis.

ILC1-like cells can cause alopecia areata by themselves.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Alopecia Areata can develop without perforin-mediated cytolysis.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Dandruff is linked to changes in the immune system of hair follicles and skin.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Alopecia areata is an autoimmune disease that targets hair follicles.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Early intervention and patient education are crucial for managing alopecia areata.